Skip to main content
Top
Published in: Rheumatology International 6/2012

01-06-2012 | Letter to the Editor

A Tunisian case–control association study of a 6q polymorphism in rheumatoid arthritis

Authors: Mariem Ben Hamad, François Cornelis, Abdellatif Maalej, Elisabeth Petit-Teixeira

Published in: Rheumatology International | Issue 6/2012

Login to get access

Abstract

Rheumatoid arthritis (RA), the most common autoimmune inflammatory disease of the joints, is a multifactorial disease, involving both genetic and environmental risk factors. TNFAIP3 (tumor necrosis factor, alpha-induced protein 3) gene located in a region of genetic susceptibility in RA is an attractive candidate to be involved in autoimmunity disorders. Our aim was to test the single nucleotide polymorphism rs6920220 located near TNFAIP3 in a case–control study in Tunisian population. The rare allele rs6920220-A was reported to have a risk effect on RA in several genome-wide association studies. Our results revealed a trend of an association of rs6920220-A allele with RA and genotypes containing this allele were in a higher proportion in RA patients than in matched controls. These findings have to be confirmed by a replication in largest RA and control groups of the same ethnic origin. TNFAIP3 gene may have a key role in autoimmunity through its action as a negative regulator of the NF-κB pathway. Further functional investigations are required to understand the mechanism by which this gene is involved in the RA pathogenesis.
Literature
1.
go back to reference Coenen MJ, Gregersen PK (2009) Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 10(2):101–111PubMedCrossRef Coenen MJ, Gregersen PK (2009) Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 10(2):101–111PubMedCrossRef
2.
go back to reference Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef
3.
go back to reference Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J et al (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39:1431–1433PubMedCrossRef Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J et al (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39:1431–1433PubMedCrossRef
4.
go back to reference Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J et al (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39:1477–1482PubMedCrossRef Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J et al (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39:1477–1482PubMedCrossRef
5.
go back to reference Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, Balsa A, Blanco FJ, Canete JD et al (2009) Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbour intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther 11:R42PubMedCrossRef Dieguez-Gonzalez R, Calaza M, Perez-Pampin E, Balsa A, Blanco FJ, Canete JD et al (2009) Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbour intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther 11:R42PubMedCrossRef
6.
go back to reference Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP et al (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350–2354PubMedCrossRef Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP et al (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350–2354PubMedCrossRef
7.
go back to reference Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet Jun 42(6):508–514CrossRef Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet Jun 42(6):508–514CrossRef
8.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
9.
go back to reference Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M et al (2010) Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 69(11):1958–1964PubMedCrossRef Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M et al (2010) Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 69(11):1958–1964PubMedCrossRef
10.
go back to reference Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R (2010) Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol 80(12):2009–2020PubMedCrossRef Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R (2010) Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol 80(12):2009–2020PubMedCrossRef
Metadata
Title
A Tunisian case–control association study of a 6q polymorphism in rheumatoid arthritis
Authors
Mariem Ben Hamad
François Cornelis
Abdellatif Maalej
Elisabeth Petit-Teixeira
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1996-6

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine